BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 1381509)

  • 21. Effects of FK-506 on the course of murine salmonellosis.
    Nichterlein T; Kretschmar M; Geginat G; Hirth K; Altenburg HP; Hof H
    J Chemother; 1996 Dec; 8(6):449-56. PubMed ID: 8981186
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunosuppressive effects of azelastine hydrochloride on contact hypersensitivity and T-cell proliferative response: a comparative study with FK-506.
    Furue M; Osada A; Chang CH; Tamaki K
    J Invest Dermatol; 1994 Jul; 103(1):49-53. PubMed ID: 7517981
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synergistic effects of Isatis tinctoria L. and tacrolimus in the prevention of acute heart rejection in mice.
    Wang Y; Qin Q; Chen J; Kuang X; Xia J; Xie B; Wang F; Liang H; Qi Z
    Transpl Immunol; 2009 Dec; 22(1-2):5-11. PubMed ID: 19766187
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Augmentation of T-cell apoptosis by immunosuppressive agents.
    Takahashi K; Reynolds M; Ogawa N; Longo DL; Burdick J
    Clin Transplant; 2004; 18 Suppl 12():72-5. PubMed ID: 15217412
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The hydroxylamine of sulfamethoxazole synergizes with FK506 and cyclosporin A, inhibiting T-cell proliferation.
    Hess DA; Bird IA; Almawi WY; Rieder MJ
    J Pharmacol Exp Ther; 1997 Apr; 281(1):540-8. PubMed ID: 9103542
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 2-Chlorodeoxyadenosine: lack of synergism with cyclosporine A and tacrolimus (FK 506).
    Nowaczyk M; Stephień-Sopniewska B; Korczak-Kowalska G; Mrowiec T; Górski A
    Arch Immunol Ther Exp (Warsz); 1995; 43(5-6):329-32. PubMed ID: 8744655
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Calmodulin antagonists inhibit human immunodeficiency virus-induced cell fusion but not virus replication.
    Srinivas RV; Bernstein H; Oliver C; Compans RW
    AIDS Res Hum Retroviruses; 1994 Nov; 10(11):1489-96. PubMed ID: 7888203
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CD4+ blood lymphocytes are rapidly killed in vitro by contact with autologous human immunodeficiency virus-infected cells.
    Nardelli B; Gonzalez CJ; Schechter M; Valentine FT
    Proc Natl Acad Sci U S A; 1995 Aug; 92(16):7312-6. PubMed ID: 7638187
    [TBL] [Abstract][Full Text] [Related]  

  • 29. HIV-1, NFAT, and cyclosporin: immunosuppression for the immunosuppressed?
    Cron RQ
    DNA Cell Biol; 2001 Dec; 20(12):761-7. PubMed ID: 11879569
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Mechanism of action of the new immunosuppressants: cyclosporin A, FK 506 and rapamycin].
    Rondeau E
    Nephrologie; 1992; 13(3):137. PubMed ID: 1379348
    [No Abstract]   [Full Text] [Related]  

  • 31. Inhibition of T-lymphocyte activation by the immunosuppressive drug FK-506.
    Kay JE; Benzie CR; Goodier MR; Wick CJ; Doe SE
    Immunology; 1989 Aug; 67(4):473-7. PubMed ID: 2475433
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Calcineurin inhibitors down-regulate iNOS expression by destabilizing mRNA.
    Hämäläinen M; Korhonen R; Moilanen E
    Int Immunopharmacol; 2009 Feb; 9(2):159-67. PubMed ID: 18692599
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Quantitative and temporal analysis of the cellular interaction of FK-506 and rapamycin in T-lymphocytes.
    Dumont FJ; Kastner C; Iacovone F; Fischer PA
    J Pharmacol Exp Ther; 1994 Jan; 268(1):32-41. PubMed ID: 7507994
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of the influence of FK 506, rapamycin, and cyclosporine on processing and presentation of particulate antigen by macrophages: assessment of a drug "carry-over" effect.
    Cooper MH; Gregory SH; Thomson AW; Fung JJ; Starzl TE; Wing EJ
    Transplant Proc; 1991 Dec; 23(6):2957-8. PubMed ID: 1721326
    [No Abstract]   [Full Text] [Related]  

  • 35. Inhibition of human insulin gene transcription by the immunosuppressive drugs cyclosporin A and tacrolimus in primary, mature islets of transgenic mice.
    Oetjen E; Baun D; Beimesche S; Krause D; Cierny I; Blume R; Dickel C; Wehner S; Knepel W
    Mol Pharmacol; 2003 Jun; 63(6):1289-95. PubMed ID: 12761338
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The inhibition of T-cell-receptor-induced Fas ligand upregulation by cyclosporine and FK 506.
    Nakajima H; Oka T
    Transplant Proc; 1996 Apr; 28(2):1052-5. PubMed ID: 8623224
    [No Abstract]   [Full Text] [Related]  

  • 37. Regulation of human insulin gene transcription by the immunosuppressive drugs cyclosporin A and tacrolimus at concentrations that inhibit calcineurin activity and involving the transcription factor CREB.
    Oetjen E; Grapentin D; Blume R; Seeger M; Krause D; Eggers A; Knepel W
    Naunyn Schmiedebergs Arch Pharmacol; 2003 Mar; 367(3):227-36. PubMed ID: 12644894
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular mechanisms of new immunosuppressants.
    Halloran PF
    Clin Transplant; 1996 Feb; 10(1 Pt 2):118-23. PubMed ID: 8680047
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 3'-Azido-3'-deoxythymidine-induced reduction in the ability of uninfected CD4-expressing cells to participate in syncytium formation.
    Buckheit RW; Germany-Decker J; Qualls-Goodwin K; Bowdon BJ; Shannon WM
    Proc Natl Acad Sci U S A; 1992 Sep; 89(17):8361-5. PubMed ID: 1355606
    [TBL] [Abstract][Full Text] [Related]  

  • 40. FK-506 and rapamycin but not cyclosporin inhibit aldosterone-stimulated sodium transport in A6 cells.
    Rokaw MD; West ME; Palevsky PM; Johnson JP
    Am J Physiol; 1996 Jul; 271(1 Pt 1):C194-202. PubMed ID: 8760046
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.